GMDA News and Press, Gamida Cell Ltd. From 08/11/21

BLA submission for omidubicel, a potentially life-saving treatment for patients with blood cancers in need of stem cell transplant, expected in fourth quarter of 2021 Commercial readiness activities underway to support potential launch in 2022 Phase 1/2 clini...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will host a conference call and live audio webcast on Wednesday, August 11, 2021, at 8:00 a.m. ET to review its second quar...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Tuesday, August 10, 2021 at 3:00 p.m. E...

Omidubicel is a first-in-class, NAM-enabled, advanced cell therapy being evaluated as a potential life-saving treatment for patients with blood cancers in need of an allogeneic hematopoietic stem cell (bone marrow) transplant The Phase 3 clinical trial achieved both primary and se...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that company management will present its corporate highlights at the following investor conferences in June: JMP Securities Life Scien...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced the appointment of Vladimir Melnikov as senior vice president, global operations and manufacturing. Mr. Melnikov brings over 25 years of...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that Julian Adams, Ph. D., chief executive officer of Gamida Cell, will participate in a fireside chat at the RBC Capital Markets Global Hea...

Image source: The Motley Fool. Gamida Cell Ltd. (NASDAQ: GMDA) Q1 2021 Earnings Call May 11, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Gamida Cell Ltd. (GMDA) Q1 2021 Earnings Call Transcript

Gamida Cell Ltd. (GMDA) Q1 2021 Results Conference Call May 11, 2021 08:00 AM ET Company Participants Josh Hamermesh - Chief Business Officer Julian Adams - CEO Michele Korfin - COO and Chief Commercial Officer Shai Lankry - Chief Commercial Officer Ronit Simantov - Chief Medical Officer Trac...

Gamida Cell (GMDA): Q1 GAAP EPS of -$0.34 beats by $0.06.Cash and cash equivalents of $174.8M.Press Release For further details see: Gamida Cell EPS beats by $0.06